MARKET

AMPE

AMPE

AMPIO PHARMA
AMEX

Real-time Quotes | Nasdaq Last Sale

0.6488
+0.0388
+6.36%
Closed 16:00 01/17 EST
OPEN
0.6150
PREV CLOSE
0.6100
HIGH
0.6631
LOW
0.6100
VOLUME
1.19M
TURNOVER
--
52 WEEK HIGH
1.310
52 WEEK LOW
0.2600
MARKET CAP
102.93M
P/E (TTM)
-15.0185
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of AMPE and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 2 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

AMPE News

  • Here is What Hedge Funds Think About Ampio Pharmaceuticals, Inc. (AMPE)
  • Insider Monkey.12/24/2019 00:57
  • Barclays sees 21% upside in J&J in premarket analyst action
  • Seeking Alpha - Article.12/19/2019 12:49
  • Roth Capital Initiates Coverage On Ampio Pharmaceuticals with Buy Rating, Announces $4 Price Target
  • Benzinga.12/19/2019 11:38
  • Roth Capital Partners Initiates Coverage On Ampio Pharmaceuticals With Buy Rating, Says Mid-2020 Release Of AP-013 Data Will Be A 'Positive, Material Investment Catalyst'
  • Benzinga.12/18/2019 21:11

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About AMPE

Ampio Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused primarily on the development of therapies to treat prevalent inflammatory conditions for which there are limited treatment options. The Company's two lead product candidates in development are Ampion for osteoarthritis of the knee and Optina for diabetic macular edema. Ampion is a sub 5000 molecular weight fraction of commercial human serum albumin (HSA). Optina is a low-dose formulation of danazol. The Ampio segment consists of its biopharmaceuticals compounds and the clinical trials associated with them. The Company is primarily developing compounds that decrease inflammation by inhibiting specific pro-inflammatory compounds by affecting specific pathways at the protein expression and at the transcription level; activating specific phosphatase or depleting available phosphate needed for the inflammation process, and decreasing vascular permeability.
More

Webull offers Ampio Pharmaceuticals Inc (AMPE) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.